Chemical induction of gut β-like-cells by combined FoxO1/Notch inhibition as a glucose-lowering treatment for diabetes

Objective: Lifelong insulin replacement remains the mainstay of type 1 diabetes treatment. Genetic FoxO1 ablation promotes enteroendocrine cell (EECs) conversion into glucose-responsive β-like cells. Here, we tested whether chemical FoxO1 inhibitors can generate β-like gut cells. Methods: We used Ng...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Takumi Kitamoto, Yun-Kyoung Lee, Nishat Sultana, Hitoshi Watanabe, Wendy M. McKimpson, Wen Du, Jason Fan, Bryan Diaz, Hua V. Lin, Rudolph L. Leibel, Sandro Belvedere, Domenico Accili
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Elsevier 2022-12-01
coleção:	Molecular Metabolism
Assuntos:	Diabetes Insulin β cell replacement FOXO1 FoxO1 inhibitor Notch inhibition
Acesso em linha:	http://www.sciencedirect.com/science/article/pii/S2212877822001934
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!